Exchange Traded Concepts, LLC Neurocrine Biosciences Inc Transaction History

Exchange Traded Concepts, LLC

$4.74 Billion
Q4 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 8,133 shares of NBIX stock, worth $997,268. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,133

Previous 7,964 2.12%

Holding current value

$997,268

Previous $916,000 21.18%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	BUY	$111.62 - $139.44 $18,863 - $23,565	169 Added 2.12%	8,133 $1.11 Million
Q3 2024 Oct 10, 2024	BUY	$114.58 - $153.15 $206,587 - $276,129	1,803 Added 29.26%	7,964 $916,000
Q2 2024 Aug 13, 2024	BUY	$130.86 - $143.19 $56,138 - $61,428	429 Added 7.48%	6,161 $848,000
Q1 2024 Apr 15, 2024	SELL	$130.4 - $143.74 $192,861 - $212,591	-1,479 Reduced 20.51%	5,732 $790,000
Q4 2023 Jan 05, 2024	BUY	$106.07 - $132.76 $2,757 - $3,451	26 Added 0.36%	7,211 $950,000
Q3 2023 Oct 18, 2023	SELL	$94.02 - $117.1 $4,983 - $6,206	-53 Reduced 0.73%	7,185 $808,000
Q2 2023 Jul 20, 2023	SELL	$89.53 - $104.87 $19,875 - $23,281	-222 Reduced 2.98%	7,238 $682,000
Q1 2023 Apr 12, 2023	SELL	$94.11 - $123.02 $113,873 - $148,854	-1,210 Reduced 13.96%	7,460 $755,000
Q4 2022 Jan 17, 2023	BUY	$106.72 - $127.06 $15,687 - $18,677	147 Added 1.72%	8,670 $1.04 Million
Q3 2022 Oct 07, 2022	SELL	$92.03 - $107.81 $39,480 - $46,250	-429 Reduced 4.79%	8,523 $905,000
Q2 2022 Jul 20, 2022	BUY	$75.79 - $100.07 $41,836 - $55,238	552 Added 6.57%	8,952 $873,000
Q1 2022 Apr 26, 2022	SELL	$72.45 - $94.81 $208,656 - $273,052	-2,880 Reduced 25.53%	8,400 $788,000
Q4 2021 Jan 13, 2022	BUY	$79.65 - $106.22 $408,604 - $544,908	5,130 Added 83.41%	11,280 $961,000
Q3 2021 Oct 18, 2021	BUY	$86.18 - $99.03 $483,469 - $555,558	5,610 Added 1038.89%	6,150 $590,000
Q2 2021 Jul 30, 2021	SELL	$89.43 - $102.27 $20,479 - $23,419	-229 Reduced 29.78%	540 $53,000
Q1 2021 Apr 20, 2021	SELL	$87.57 - $119.4 $27,672 - $37,730	-316 Reduced 29.12%	769 $75,000
Q4 2020 Jan 19, 2021	BUY	$86.91 - $108.33 $94,297 - $117,538	1,085 New	1,085 $104,000
Q2 2020 Jul 15, 2020	SELL	$85.09 - $130.36 $2,467 - $3,780	-29 Closed	0 $0
Q1 2020 Apr 14, 2020	BUY	$75.11 - $113.76 $2,178 - $3,299	29 New	29 $3,000

Others Institutions Holding NBIX

# of Institutions

642

Shares Held

94.3M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.7B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Neurocrine Biosciences Inc Transaction History